FDA Ethics Panel Tackles Pediatric MCM
By Catherine Shaffer
Monday, September 9, 2013
The Pediatric Ethics Subcommittee of the Pediatric Advisory Committee convened Monday morning for a two-day meeting to hammer out the difficult ethical issues related to development of pediatric medical countermeasures (MCM).
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.